What to know about a mifepristone maker asking the Supreme Court to restore access to the pill by mail
Summary
A company that makes the abortion drug mifepristone asked the U.S. Supreme Court to block a recent court ruling that stopped the mailing of the drug. The appeals court ruling requires the pill to be given only in person, which affects access nationwide while the case continues.Key Facts
- Danco Laboratories, maker of mifepristone, asked the Supreme Court to stop a 5th Circuit Court ruling.
- The 5th Circuit Court blocked mail-order sales of mifepristone, requiring in-person pickup.
- The ruling challenges FDA rules that allowed mailing the drug after a telehealth visit.
- The decision affects all states, even those without abortion bans.
- Louisiana sued the FDA, saying its rules undermine the state's abortion ban.
- Mifepristone was approved in 2000 and is widely seen as safe and effective.
- About one in four abortions in the U.S. are done through pills prescribed online.
- Some states have passed laws to protect those who prescribe or send abortion pills by mail.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.